Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Xortx Therapeutics Inc (XRTXF)

Xortx Therapeutics Inc (XRTXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
XORTX Therapeutics Announces Closing of US$12 Million Public Offering Globe Newswire - Fri Oct 15, 2021

CALGARY, Alberta, Oct. 15, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX | NASDAQ: XRTX), a pharmaceutical...

XRX.CN : 4.800 (unch)
XRTX : 1.3100 (+6.14%)
XRTXF : 0.4387 (-1.50%)
XORTX Announces Results from Mount Sinai’s COVID-19 Clinical Study Globe Newswire - Thu Oct 14, 2021

Early, High Uric Acid is Independently Associated with Acute Kidney Injury and Mortality in COVID-19...

XRX.CN : 4.800 (unch)
XRTX : 1.3100 (+6.14%)
XRTXF : 0.4387 (-1.50%)
XORTX to Present at the LD Micro Main Event Globe Newswire - Thu Oct 14, 2021

Virtual Corporate Presentation – October 14, 2021 – 10 am ET...

XRX.CN : 4.800 (unch)
XRTX : 1.3100 (+6.14%)
XRTXF : 0.4387 (-1.50%)
XORTX Therapeutics Announces Pricing of US$12 Million Public Offering and Nasdaq Listing Globe Newswire - Wed Oct 13, 2021

CALGARY, Alberta, Oct. 13, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a pharmaceutical...

XRX.CN : 4.800 (unch)
XRTXF : 0.4387 (-1.50%)
Virtual Conference for Life Sciences Companies Broadcast Live March 25th, 2021 Globe NewsWire - Fri Mar 19, 2021

Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com

OTCM : 53.0500 (-1.12%)
SEOVF : 0.1677 (-1.93%)
SHGFF : 5.6450 (+1.71%)
BABYF : 0.0226 (+8.13%)
XRTXF : 0.4387 (-1.50%)
CRTPF : 2.3000 (+5.50%)
VVIVF : 0.0328 (+1.86%)
AVCNF : 0.1684 (-0.94%)
ORXOY : 0.9950 (+2.05%)
SVA.VN : 1.570 (+6.08%)
SHG.VN : 6.800 (+5.92%)
BABY.VN : 1.170 (unch)
XORTX to Present at "Zoom With LD MICRO" AccessWire - Tue Mar 16, 2021

CALGARY, AB / ACCESSWIRE / March 16, 2021 / XORTX Therapeutics Inc. ("XORTX" or the "Company") (CSE:XRX) (OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive...

XRX.CN : 4.800 (unch)
XRTXF : 0.4387 (-1.50%)
XORTX to Present and Participate in the Sachs 14th Annual European Life Sciences CEO Forum 2021 AccessWire - Tue Mar 9, 2021

CALGARY, AB / ACCESSWIRE / March 9, 2021 / XORTX Therapeutics Inc. ("XORTX" or the "Company") (CSE:XRX)(OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive...

XRTXF : 0.4387 (-1.50%)
XRX.CN : 4.800 (unch)
XORTX Files New Provisional Patent to Treat and Protect Individuals Most at Risk to Severe Viral Infection AccessWire - Mon Mar 8, 2021

Compositions and Methods for Enhancing Anti-viral Therapies CALGARY, AB / ACCESSWIRE / March 8, 2021 / XORTX Therapeutics Inc. ("XORTX" or the "Company") (CSE:XRX) (OTCQB:XRTXF), a biopharmaceutical company...

XRTXF : 0.4387 (-1.50%)
XRX.CN : 4.800 (unch)
XORTX to Present at BIO CEO and Investor Conference; Strategies to Decrease Acute and Chronic Kidney Injury, Co-morbidity and Mortality AccessWire - Wed Feb 17, 2021

CALGARY, AB / ACCESSWIRE / February 17, 2021 / XORTX Therapeutics Inc. ("XORTX" or the "Company") (CSE:XRX)(OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat...

XRX.CN : 4.800 (unch)
XRTXF : 0.4387 (-1.50%)
XORTX Announces Over Subscribed Private Placement AccessWire - Mon Feb 8, 2021

CALGARY, AB / ACCESSWIRE / February 8, 2021 / XORTX Therapeutics Inc. ("XORTX" or the "Company") (CSE:XRX)(OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat...

XRX.CN : 4.800 (unch)
XRTXF : 0.4387 (-1.50%)

Barchart Exclusives

After Underperforming in 2024, is Mega-Cap Microsoft Stock Still a Buy? Barchart - 1 hour ago
MSFT has underperformed the markets this year, but analysts still like the stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot